Zeng X, Zhang YD, Ma RY, Chen YJ, Xiang XM, Hou DY et al (2022) Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis. Mil Med Res 9:25

CAS  PubMed  PubMed Central  Google Scholar 

Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK (2021) The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun 92:223–233

Article  PubMed  Google Scholar 

Pan B, Sun J, Liu Z, Wang L, Huo H, Zhao Y et al (2021) Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms. J Adv Res 33:215–225

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia Q, Zhan G, Mao M, Zhao Y, Li X (2022) TRIM45 causes neuronal damage by aggravating microglia-mediated neuroinflammation upon cerebral ischemia and reperfusion injury. Exp Mol Med 54:180–193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li P, Zhang Y, Liu H (2019) The role of Wnt/β-catenin pathway in the protection process by dexmedetomidine against cerebral ischemia/reperfusion injury in rats. Life Sci 236:116921

Article  CAS  PubMed  Google Scholar 

Sun YB, Zhao H, Mu DL, Zhang W, Cui J, Wu L et al (2019) Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis 10:167

Article  PubMed  PubMed Central  Google Scholar 

Tasbihgou SR, Barends CRM, Absalom AR (2021) The role of dexmedetomidine in neurosurgery. Best Pract Res Clin Anaesthesiol 35:221–229

Article  CAS  PubMed  Google Scholar 

Mei B, Li J, Zuo Z (2021) Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor. Brain Behav Immun 91:296–314

Article  CAS  PubMed  Google Scholar 

Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A et al (2021) Dexmedetomidine or propofol for Sedation in mechanically ventilated adults with Sepsis. N Engl J Med 384:1424–1436

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE et al (2019) Early Sedation with Dexmedetomidine in critically ill patients. N Engl J Med 380:2506–2517

Article  CAS  PubMed  Google Scholar 

Kida K, Ohtani N, Shoji K, Yasui Y, Masaki E (2008) Postoperative pain status after intraoperative systemic dexmedetomidine and epidural neostigmine in patients undergoing lower abdominal surgery. Eur J Anaesthesiol 25:869–875

Article  CAS  PubMed  Google Scholar 

Lee JR, Joseph B, Hofacer RD, Upton B, Lee SY, Ewing L et al (2021) Effect of dexmedetomidine on sevoflurane-induced neurodegeneration in neonatal rats. Br J Anaesth 126:1009–1021

Article  CAS  PubMed  Google Scholar 

Unchiti K, Leurcharusmee P, Samerchua A, Pipanmekaporn T, Chattipakorn N, Chattipakorn SC (2021) The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: evidence from in vitro and in vivo studies. Eur J Neurosci 54:7006–7047

Article  CAS  PubMed  Google Scholar 

Shehabi Y, Serpa Neto A, Howe BD, Bellomo R, Arabi YM, Bailey M et al (2021) Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial. Intensive Care Med 47:455–466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Persson N, Uusalo P, Nedergaard M, Lohela TJ, Lilius TO (2022) Could dexmedetomidine be repurposed as a glymphatic enhancer? Trends Pharmacol Sci 43:1030–1040

Article  CAS  PubMed  Google Scholar 

Tian M, Wang W, Wang K, Jin P, Lenahan C, Wang Y et al (2021) Dexmedetomidine alleviates cognitive impairment by reducing blood-brain barrier interruption and neuroinflammation via regulating Th1/Th2/Th17 polarization in an experimental sepsis model of mice. Int Immunopharmacol 101:108332

Article  CAS  PubMed  Google Scholar 

Chen L, Cao J, Cao D, Wang M, Xiang H, Yang Y et al (2019) Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: an in vivo and in vitro study. Life Sci 235:116553

Article  CAS  PubMed  Google Scholar 

Zhai M, Liu C, Li Y, Zhang P, Yu Z, Zhu H et al (2019) Dexmedetomidine inhibits neuronal apoptosis by inducing Sigma-1 receptor signaling in cerebral ischemia-reperfusion injury. Aging 11:9556–9568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu W, Shao C, Zang C, Sun J, Xu M, Wang Y (2021) Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis. BMC Anesthesiol 21:203

Article  PubMed  PubMed Central  Google Scholar 

Wang YQ, Tang YF, Yang MK, Huang XZ (2019) Dexmedetomidine alleviates cerebral ischemia-reperfusion injury in rats via inhibition of hypoxia-inducible factor-1α. J Cell Biochem 120:7834–7844

Article  CAS  PubMed  Google Scholar 

Yu W, Lyu J, Jia L, Sheng M, Yu H, Du H (2020) Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats. Oxid Med Cell Longev. ; 2020: 7385458

Tong L, Cai M, Huang Y, Zhang H, Su B, Li Z et al (2014) Activation of K(2)P channel-TREK1 mediates the neuroprotection induced by sevoflurane preconditioning. Br J Anaesth 113:157–167

Article  CAS  PubMed  Google Scholar 

Fan J, Du J, Zhang Z, Shi W, Hu B, Hu J et al (2022) The Protective effects of Hydrogen Sulfide New Donor Methyl S-(4-Fluorobenzyl)-N-(3,4,5-Trimethoxybenzoyl)-l-Cysteinate on the ischemic stroke. Molecules ; 27

Sawicka M, Szymczak RK (2022) Paradoxical embolism to the central nervous system in a young Polish woman on a trek in the Himalayas. J Travel Med ; 29

Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M et al (2004) TREK-1, a K + channel involved in neuroprotection and general anesthesia. EMBO J 23:2684–2695

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang N, Nie H, Zhang Y, Han H, Wang S, Liu W et al (2022) Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway. Inflamm Res 71:93–106

Article  CAS  PubMed  Google Scholar 

Lv H, Li Y, Cheng Q, Chen J, Chen W (2021) Neuroprotective effects against cerebral ischemic Injury exerted by Dexmedetomidine via the HDAC5/NPAS4/MDM2/PSD-95 Axis. Mol Neurobiol 58:1990–2004

Article  CAS  PubMed  Google Scholar 

Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A et al (2017) Effect of Dexmedetomidine on Mortality and Ventilator-Free days in patients requiring mechanical ventilation with Sepsis: a Randomized Clinical Trial. JAMA 317:1321–1328

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan X, Coburn M, Rossaint R, Sanders RD, Waesberghe JV, Kowark A (2018) Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth 121:384–397

Article  CAS  PubMed  Google Scholar 

Mahmoud M, Mason KP (2015) Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth 115:171–182

Article  CAS  PubMed  Google Scholar 

Guo Q, Ma M, Yu H, Han Y, Zhang D (2023) Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1. Ann Med 55:2209735

Article  PubMed  PubMed Central  Google Scholar